<?xml version="1.0" ?>
<document id="30123056">
  <sentence id="30123056.s0" text="In 128 female patients of the recruited UCC cohort, patients who carried at least one deletion allele of &lt;i&gt;adenylate cyclase-inhibiting dopamine receptor signaling pathway&lt;/i&gt; rs1799732 showed a higher incidence of having an invasive stage (AOR=2.585, 95% CI: 1.066~6.264, &lt;i&gt;p&lt;/i&gt;=0.032) and a large tumor (AOR=2.778, 95% CI: 1.146~6.735, &lt;i&gt;p&lt;/i&gt;=0.021).">
    <entity charOffset="108-172" id="30123056.s0.e0" ontology_id="GO_0007195" text="adenylate cyclase-inhibiting dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="302-307" id="30123056.s0.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="30123056.s0.e0" e2="30123056.s0.e1" id="30123056.s0.p0" relation="true"/>
  </sentence>
  <sentence id="30123056.s1" text="Further analyses of The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) datasets revealed correlations of the expression of adenylate cyclase-inhibiting dopamine receptor signaling pathway with an invasive tumor, tumor metastasis, and the lower survival rate in patients with UCC.">
    <entity charOffset="137-201" id="30123056.s1.e0" ontology_id="GO_0007195" text="adenylate cyclase-inhibiting dopamine receptor signaling pathway" type="GO"/>
    <entity charOffset="219-224" id="30123056.s1.e1" ontology_id="HP_0002664" text="tumor" type="HP"/>
    <pair e1="30123056.s1.e0" e2="30123056.s1.e1" id="30123056.s1.p0" relation="true"/>
  </sentence>
</document>
